TABLE 3.
Changes in IVIG over time in patients with frequent fluctuations and patients with no or minimal fluctuations
| High fluctuaters (n = 12) | Low fluctuaters (n = 11) | p | ||
|---|---|---|---|---|
| IVIG taper attempted, % (n) | 92% (11 of 12) | 82% (9 of 11) | 1.00 | |
| IVIG taper not successful, % (n) | 45% (5 of 11) | 44% (4 of 9) | 1.00 | |
| IVIG taper partially successful, % (n) | 18% (2 of 11) | 22% (2 of 9) | 1.00 | |
| IVIG taper completely successful, % (n) | 36% (4 of 11) | 33% (3 of 9) | 1.00 | |
| IVIG dose, mean (gm/kg) | Baseline | 0.91 | 0.89 | 0.76 |
| At last follow‐up | 0.75 | 0.77 | 0.89 | |
| IVIG frequency, mean (wk) | Baseline | 4.2 | 3.6 | 0.40 |
| At last follow‐up | 3.1 | 3.9 | 0.42 | |
| IVIG per 4 wk, mean (g/kg) | Baseline | 1.1 | 1.0 | 0.77 |
| At last follow‐up | 1.1 | 0.8 | 0.47 | |
Abbreviation: IVIG, intravenous immunoglobulin.